A/APublished research associates this genotype (two copies of the reported risk allele) with a higher likelihood of Objective response to lithium treatment compared to the general population.
A/GPublished research associates this genotype (one copy of the reported risk allele) with an intermediate association with Objective response to lithium treatment.
G/GPublished research associates this genotype with typical/baseline likelihood of Objective response to lithium treatment — no copies of the reported risk allele.
Molecular psychiatry · 2016 · PMID 26503763 · open access
Questions about rs116323614
What is rs116323614?
rs116323614 is a single position in the genome, in or near the SESTD1 gene. Published research associates it with objective response to lithium treatment. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.
What conditions is rs116323614 linked to?
On MyGeneLog this position is linked to Bipolar Disorder. The research behind each link, and its sources, are set out on that condition page.
Does having rs116323614 mean I will get this?
No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.
Where does the information about rs116323614 come from?
GWAS Catalog, Mol Psychiatry 2015, PMID:26503763. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.